Specialized Posaconazole Treatment Solutions for Unique Environments
Legal Citation
Summary of the Inventive Concept
The inventive concept adapts posaconazole treatment for specific, narrow markets and unique operational environments, providing targeted solutions for high-security needs, disaster relief, extreme weather conditions, remote areas, and graft-versus-host disease.
Background and Problem Solved
The original patent focuses on methods of treatment using posaconazole for various hematological malignancies and infections. However, it lacks consideration for specific, high-risk environments where standard treatment protocols may not be effective. This inventive concept addresses the limitations of the original patent by providing specialized variations and niche solutions for these unique scenarios.
Detailed Description of the Inventive Concept
The inventive concept comprises five specialized variations: (1) a method for treating immunocompromised patients in high-security isolation units, (2) a system for managing treatment of patients with hematologic malignancies in disaster relief settings, (3) a method for treating patients with oropharyngeal candidiasis in extreme weather conditions, (4) a system for providing posaconazole treatment to patients in remote areas, and (5) a method for treating patients with graft-versus-host disease in unique operational environments. Each variation incorporates posaconazole as a key component, with modifications to dosing, administration, and monitoring tailored to the specific environment.
Novelty and Inventive Step
The inventive concept's novelty lies in its adaptation of posaconazole treatment for specific, high-risk environments not addressed by the original patent. The inventive step resides in the unique combinations of posaconazole with other therapies, monitoring systems, and administration methods tailored to each environment.
Alternative Embodiments and Variations
Alternative embodiments may include variations in posaconazole dosing, administration routes, and monitoring systems. Additional variations could involve integrating posaconazole with other therapies, such as immunosuppressive treatments, or incorporating AI-powered monitoring systems for real-time patient tracking.
Potential Commercial Applications and Market
The inventive concept has significant commercial potential in the pharmaceutical and healthcare industries, particularly in niche markets such as disaster relief, high-security facilities, and remote healthcare services. Target industries include pharmaceutical companies, healthcare providers, and medical device manufacturers.
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Pharmaceutical treatment methods, specifically antifungal prophylaxis and treatment for immunocompromised patients with hematologic malignancies
Person of Ordinary Skill (PHOSITA) Profile
A clinical pharmacologist or infectious disease specialist with expertise in antifungal medications, immunosuppressive treatments, and patient management strategies for high-risk patient populations
Obviousness Rationale
A PHOSITA would recognize that the PTD's variations represent predictable extensions of the source patent's core teachings about posaconazole treatment for immunocompromised patients. The disclosed environments and administration modifications represent standard clinical adaptations that would be obvious to a skilled practitioner seeking to optimize treatment in challenging medical scenarios. The fundamental therapeutic approach remains consistent with the original patent's prophylactic and treatment strategies.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,548 |
|---|---|
| Title | Methods of treatment |
| Assignee(s) | BOW RIVER LLC |